Clinical studies
Phase I
-
Gentofte University Hospital, Gentofte, Denmark
Investigator, Professor Jesper Sonne
Phase II
-
University Hospital, Nijmegen, the Netherlands
Investigator, Professor Jelle Barentz -
Karolinska University Hospital, Huddinge, Sweden
Investigators, Professor Peter Aspelin, Professors Nils Albiin and Torkel Brismar -
Charité University Hospital, Berlin, Germany
Investigators, Professor Bert Ham and Professor M Taupitz -
Sahlgren University Hospital, Gothenburg, Sweden
Investigators, Professor Mikael Hellström and Professor Mats Andersson
Use under
“Compassionate use program” Copenhagen University Hospital, Herlev, Denmark
Current total number of patients in different clinical programs is approximately 200.







